ARKK stock forecast, quote, news & analysis

Key Takeaways

• ARK Innovation ETF (ARKK) declined about 10.6% over the last 30 days, retreating from roughly $91.70 to $81.99 as high-beta growth stocks pulled back.
• Despite the short-term slide, the fund remains up about 11% over the last quarter, reflecting a sharp September rally followed by October profit-taking.
• TSLA (Tesla), the largest holding, and crypto-linked names such as COIN (Coinbase) and HOOD (Robinhood) have been key swing factors.
• The portfolio is actively managed, concentrated across roughly 40-plus holdings, with an expense ratio of 0.75% and a beta above 2.0 versus the S&P 500.
• Technology, healthcare and genomics, and financial-services exposures dominate the fund, contributing to outsized volatility relative to broad benchmarks.
• For deeper analysis of this ticker, review its Price Targets and Forecast on dedicated pages.
• Explore Trending AI Robots to discover automated strategies aligned with current market conditions.

ARK Innovation ETF (ARKK) Overview and Portfolio Exposure

ARK Innovation ETF is an actively managed, thematic exchange-traded fund (ETF) that seeks long-term capital growth by investing in companies positioned to benefit from disruptive innovation. Launched in October 2014, the fund typically allocates at least 65% of assets to domestic and foreign equities tied to themes such as artificial intelligence, genomics, fintech, robotics, and next-generation internet.

The fund maintains a concentrated portfolio of roughly 40-plus positions, which magnifies single-stock influence on returns. Its largest holdings include TSLA (Tesla), Space Exploration Technologies (SpaceX), TEM (Tempus AI), Circle Internet Group, COIN (Coinbase), CRSP (CRISPR Therapeutics), SHOP (Shopify), and HOOD (Robinhood). Sector exposure skews toward technology, healthcare and genomics, financial services, and consumer discretionary. The fund charges a 0.75% expense ratio, and its elevated beta and high realized volatility explain why short-term price swings routinely exceed those of broad market indexes.

ARK Innovation ETF (ARKK) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ARKK fell approximately 10.6%, declining from a closing level near $91.70 to about $81.99. The move was not a straight-line decline; the fund initially extended its September strength into early October before giving back gains as selling pressure built across high-multiple growth equities. The pattern was volatile rather than gradual, consistent with the fund's historically elevated volatility profile.

The picture is markedly different over the last quarter. From a closing level near $73.83 roughly three months earlier, ARKK advanced approximately 11% through late October. This divergence between the trailing 30-day and quarterly figures highlights a fund that experienced a powerful risk-on rally, followed by a meaningful consolidation and pullback. The recent leg lower trimmed, but did not erase, the prior quarter's advance.

What Drove ARKK Price in the Last 30 Days

The recent decline was driven primarily by weakness in the fund's largest and most influential positions. TSLA, the top holding at roughly 9% to 10% of assets, and crypto-linked names such as COIN and HOOD are high-beta securities whose pullbacks disproportionately weigh on the portfolio. Genomics and biotech positions, including CRSP and TWST (Twist Bioscience), also contributed to volatility.

Broader market conditions amplified the move. Rising interest-rate sensitivity, shifting risk appetite, and profit-taking after a strong rally all pressured speculative growth and thematic segments. Because ARKK's holdings cluster in long-duration, innovation-driven equities, the fund tends to underperform when investors rotate toward lower-beta or value-oriented exposures. These dynamics translated a moderate cooling in the underlying names into a double-digit decline in the ETF's share price.

What Drove ARKK Performance Over the Last Quarter

The three-month gain of roughly 11% reflects a sustained recovery in disruptive-growth equities that began in the summer and accelerated into September. A rebound in Tesla shares, a revival across the cryptocurrency and fintech ecosystem, and renewed strength in select biotech and genomics names supported the advance. The fund's heavy exposure to artificial-intelligence-adjacent software and data holdings also benefited from persistent investor interest in AI investment themes.

This rally occurred against a backdrop of improving risk appetite and stabilization in rate expectations, which favored long-duration growth assets. However, the same concentration that fueled the quarterly upside also made the fund vulnerable to the subsequent October drawdown, underscoring the two-sided nature of its performance profile.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery platform designed to help investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. It streamlines the process of identifying trending names, breakout candidates, and actionable setups that would be difficult to surface through manual screening. For investors monitoring high-volatility vehicles such as ARKK, the screener offers a structured way to evaluate positioning and momentum across the fund's underlying themes and peers. Explore the AI Screener to refine your research workflow.

ARKK ETF Outlook: What Investors Should Watch Next

Going forward, the fund's trajectory is likely to remain closely tied to the performance of its largest holdings and to the broader risk environment. Investors should monitor interest-rate expectations and inflation trends, since rising yields historically pressure the long-duration, innovation-focused equities that dominate the portfolio. Developments in electric vehicles, autonomous technology, and the cryptocurrency and fintech sectors will remain key swing factors given the fund's Tesla and digital-assets exposure.

Additionally, progress across artificial intelligence, genomics, and biotech — including the earnings cycles of major positions such as TSLA, COIN, and CRSP — will influence sentiment. Capital flows into and out of the fund, shifts in institutional positioning, and broader sector rotation between growth and value will also shape near-term volatility. The fund's concentrated structure means both opportunities and risks can materialize quickly, making ongoing monitoring of its largest positions and sector allocation essential.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations